In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the FDA approval of Rejoyn, the first prescription digital treatment for major depressive disorder. They also discuss the ongoing drug shortage crisis, as well as changes coming out of the Centers for Medicare & Medicaid Services and the impact those decisions will have over the next year.

Podcast Tags: healthcare, healthcare news, life sciences, health policy, public health, depression, mental health, digital treatment, drugs, pharmaceuticals, shortages, medications, FDA, CMS, Medicare Advantage, breakthrough technology, medical devices

Source Links:

• FDA clears first digital treatment for depression, but experts caution that research is still early
• Number of ongoing US drug shortages reaches new high, pharmacist group says
• FDA commissioner tells lawmakers his agency needs more authority to prevent drug shortages
• CMS final rule on broker comp, health equity could shake up Medicare Advantage
• Medicare official says breakthrough device reimbursement rule coming in early summer

Panel – Jen Burke, Mindy McGrath, Ryan Hummel

Research & Production – Anna Briccetti, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic’s Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, to discuss where we see health organizations experimenting with AI and what it will take for them to achieve their long-term AI ambitions.

To learn more about implementing AI within your organization, check out our recent insight: Why AI fails or flourishes: The underestimated role of culture.

Podcast Tags: health, healthcare, healthcare news, generative AI, innovation, responsible use, ChatGPT

Source Links:

• The Unexpected Winners of the ChatGPT Generative AI Revolution
• Generative AI in healthcare: Emerging use for care
• US healthcare leadership: How to respond and thrive
• How Can AI Improve Health Care?
• Envisioning Healthcare in a Post-COVID-19 World
• Three-quarters of health professionals project widespread AI adoption
• 5 Key Healthcare Industry Trends to Watch in 2024
• What Do We Mean When We Talk About “AI Democratisation”?

Panel – Jen Burke, Michael Hudson, Mindy McGrath, Todd Quartiere

Research & Production – Danielle Lewis, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.

In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues.

Podcast Tags: healthcare, healthcare news, life sciences, public health, France, medical, bacteria, cancer, immunotherapy, chemotherapy, microbiome, rare disease, Germany, Italy, health disparity

Source Links:

• Dutch hospitals use AI to solve no-show patient problems that cost them millions
• Cancellations of NHS care are having serious impacts on two-thirds of patients
• Would charging patients for missed appointments help fund the NHS?
• GP \’no shows\’ cost Norfolk NHS more than 1m in a one month
• France planning €5 no-show fees in a bid to improve community healthcare
• France divided over ‘no-show tax’ for patients failing medical appointments
• Researchers compile detailed catalog of bacteria living in cancer metastases
• Boehringer builds out cancer capabilities with $500M deal for bacteria-focused Swiss biotech
• The key to young onset bowel cancer may be gut bacteria
• The mystery of microbes that live inside tumours
• Diversity of Bacteria in Cancer Metastases
• It’s the Little Things: A Role for Bacteria in Cancer Treatment
• The UK is missing out on EU collaboration to improve treatment for rare diseases
• Overcoming the burden of rare diseases in Europe
• Stronger together in the fight against rare diseases
• Is Europe on track to be the leader in rare diseases?
• Right here, right now European public health policies must start giving people living with rare diseases a fair chance
• New rare diseases action plan on horizon, Europe at turning point
• Europe needs new 360 rare diseases strategy

Panel – Jack Young, Jen Burke, Ollie May

Research & Production – Karan Pandya

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.